2006.

• Dec.19.2006

  Announcement of the Launch of Elaspol® 100 for Injection for Acute Lung Injury Associated with SIRS in Korea(51 KB)

• Oct.26.2006

  Ono Enters into License Agreement with Sapphire Therapeutics, Inc. in Japan,Korea and Taiwan - New Drug for the Treatment of Cancer Anorexia/Cachexia -(72 KB)

• Oct.25.2006

  Announcement of Approval of Additional Indications for Onoact® 50 for Injection, Short-Acting Selective β1 Blocker(91 KB)

• Oct.23.2006

  Merck & Co, Inc. Announced Approval of JANUVIA™ (INN: sitagliptin),a new oral treatment of diabetes, by the US FDA(129 KB)

• Oct.02.2006

  Announcement on Acquisition of the Company's Own Shares (pursuant to the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Corporate Law of Japan)(60 KB)

• Aug.04.2006

  Revisions of the Interim and Full Year Business Forecasts for FY2006(83 KB)

• Aug.04.2006

  Investigational New Class of Oral Medication for Patients with Type 2 Diabetes, Sitagliptin (a DPP-4 inhibitor), Begins Phase III Clinical Trials in Japan(34 KB)

• Aug.01.2006

  Allowance of an investigational new drug application (IND) for ONO-4538 / MDX-1106, a fully human anti-PD-1 antibody(102 KB)

• Jul.20.2006

  Results of Phase II / III Studies of Rivastigmine Patch, the World's First Transdermal Therapy for Alzheimer's Disease, Were Presented at OCAD(181 KB)

• Jul.10.2006

  Application Filed for the Osteoporosis Treatment ONO-5920/YM529 in Japan(74 KB)

• Jul.07.2006

  Ono Entered Into Drug Discovery Agreement on Kinases with Locus Pharmaceuticals, Inc.(15 KB)

• Jun.14.2006

  Results of Phase III Studies of Sitagliptin, new oral treatment of diabetes, were presented by Merck & Co., Inc. at ADA (The 2nd Announcement)(119 KB)

• Jun.12.2006

  Results of Phase III Studies of Sitagliptin, new oral treatment of diabetes,were presented by Merck & Co., Inc. at ADA(251 KB)

• May.15.2006

  Announcement on Change of Audit Corporation(10 KB)

• May.15.2006

  Introduction of Interim dividend(10 KB)

• May.15.2006

  Announcement on Changes of Representative Directors and Members of the Board of Directors(58 KB)

• Apr.06.2006

  Announcement on Changes of Members of the Board of Directors(53 KB)

• Mar.28.2006

  Entered Into New Collaborative Research Agreement with Medarex for Antibody Product(78 KB)

• Mar.22.2006

  Licensing Agreement on PDE4 Inhibitor ONO-6126(63 KB)

• Mar.06.2006

  Ono resolved increase in dividends projected for the fiscal year 2005 (ending on March 31st,2006)(134 KB)